EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY-NC-ND 4.0

Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population‐based cohort study

Unnur Gudnadottir iD, Njeri Kamau, Romina Fornes, Minh Hanh Nguyen, Steven Callens, Emma Fransson, Lars Engstrand, Robin Bruyndonckx, Nele Brusselaers

Acta Obstetricia et Gynecologica Scandinavica · 2024-08 · 103 (8) · 1596-1605

DOI: 10.1111/aogs.14864 ↗

At a glance

Kohortenstudie in Acta Obstetricia et Gynecologica Scandinavica, published online on 2024-06-03. Written by Unnur Gudnadottir and 8 co-authors. Institution: Department of Microbiology Tumor and Cell Biology, center for Translational Microbiome Research, Karolinska Institutet, Stockholm, Sweden. Major MEDLINE topics: Depression, Postpartum, Anti-Bacterial Agents. Cited 5 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Comisión Nacional de Investigación Científica y Tecnológica (CONICYT), Fonds Wetenschappelijk Onderzoek, Consejo Nacional de Innovación, Ciencia y Tecnología.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Postpartum depression is one of the most common non‐obstetric postnatal complications. As the microbiome (and gut–brain axis) as well as inflammation may be involved in the mechanism, we aimed to assess if antibiotic or gastric acid inhibition use during pregnancy affects the risk of postpartum depression (clinical diagnosis and/or antidepressant use up to 1 year after childbirth). Material and Methods This population‐based cohort study used first singleton pregnancy resulting in a live birth in Sweden from 2006 to 2016. Women with history of depression were excluded. Multivariable logistic regression models were used to assess the impact of antibiotics and gastric acid inhibitors and other risk factors, presented as odds ratios (ORs) with 95% confidence intervals (CI).

Results

Overall, 29% of all 10 666 women with postpartum depression were exposed to antibiotics and 6.2% to gastric acid inhibitors, compared to, respectively, 21% and 3.2% of 613 205 women without postpartum depression. Antibiotic use during pregnancy was associated with postpartum depression (OR 1.43, 95% CI 1.37–1.49), particularly for quinolones and other antibacterials (including nitroimidazole derivatives). Gastric acid inhibition was associated with an even higher risk than antibiotics (OR 2.04, 95% CI 1.88–2.21). Both antibiotics and gastric acid inhibitors suggested higher risk with increased dose in a dose–response analysis.

Conclusions

The use of antibiotics and gastric acid inhibition drugs during pregnancy appeared to be associated with a higher risk of postpartum depression. However, it is important to consider that other predisposing factors could contribute to this increased risk, even after excluding individuals with a history of depression.

Subjects

MeSH terms (MEDLINE)

Depression, PostpartumAnti-Bacterial AgentsHumansFemalePregnancyAdultSwedenCohort StudiesRisk FactorsProton Pump Inhibitors

Author keywords

antibioticsanti‐acidsgastric acid inhibitionmicrobiomemultiple logistic regressionpostnatal depressionpregnancy

Substances

Anti-Bacterial AgentsProton Pump Inhibitors

Authors and institutions

  • Department of Microbiology Tumor and Cell Biology, center for Translational Microbiome Research, Karolinska Institutet, Stockholm, Sweden.
  • Interuniversity Institute for Biostatistics and statistical Bioinformatics (I‑BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium.
  • School of Obstetrics, Faculty of Health Care Sciences, Universidad San Sebastián, Santiago, Chile.
  • Department of General Internal Medicine, Ghent University Hospital, Ghent, Belgium.
  • Department of Women's and Children's Health, Uppsala University, Sweden.
  • Global Health Institute, Department of Family Medicine and Population Health, Antwerp University, Antwerp, Belgium.

ORCID profiles: Unnur Gudnadottir

Funding

  • Comisión Nacional de Investigación Científica y Tecnológica (CONICYT)
  • Fonds Wetenschappelijk Onderzoek
  • Consejo Nacional de Innovación, Ciencia y Tecnología

Cite

APA

Gudnadottir, U., Kamau, N., Fornes, R., Nguyen, M. H., Callens, S., Fransson, E., Engstrand, L., Bruyndonckx, R., & Brusselaers, N. (2024). Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica, 103(8), 1596-1605. https://doi.org/10.1111/aogs.14864

Vancouver

Gudnadottir U, Kamau N, Fornes R, Nguyen MH, Callens S, Fransson E, et al. Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2024;103(8):1596-1605. doi:10.1111/aogs.14864

BibTeX
@article{Gudnadottir2024,
  author = {Gudnadottir, Unnur and Kamau, Njeri and Fornes, Romina and Nguyen, Minh Hanh and Callens, Steven and Fransson, Emma and Engstrand, Lars and Bruyndonckx, Robin and Brusselaers, Nele},
  title = {Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population‐based cohort study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  volume = {103},
  number = {8},
  pages = {1596--1605},
  doi = {10.1111/aogs.14864}
}
Start for free →